| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.24 | 0.0004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |